CompletedPhase 3NCT03671616

Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 Months

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Statens Serum Institut
Principal Investigator
Ingrid Kromann
Statens Serum Institut
Intervention
IPV-Al SSI(biological)
Enrollment
666 target
Eligibility
All sexes
Timeline
20182018

Study locations (1)

Collaborators

Bill and Melinda Gates Foundation · Larix A/S · Vaxtrials S.A. · AJ Vaccines A/S

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03671616 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis

← Back to all trials